← Eichor
Study identifier: NCT06991725 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Botulinum Neurotoxin for Children With CP: a Delicate Balance Between Clinical Benefits and Muscular Harm

Condition: Spastic Cerebral Palsy (sCP)  ·  Sponsor: Universitaire Ziekenhuizen KU Leuven

PhaseN/A
Planned participants51
Who can joinAll sexes, 2 Years to 16 Years
Healthy volunteersYes

About this study

A cross-sectional design study will be carried out to explore the morphological muscle properties and alterations in muscle composition on a macroscopic level in children with spastic cerebral palsy (CP). Muscle composition will be assessed using quantitative Magnetic Resonance Imaging (qMRI) and shear wave elastography (SWE), while macroscopic muscle size properties will be evaluated through 'Three-dimensional freehand ultrasound (3DfUS).

This description comes directly from the study's public registry record.

Talk to the study team

Charlotte Lambrechts  ·  +32489421264  ·  charlotte.lambrechts@kuleuven.be

Julie Stegen  ·  +32477273954  ·  julie.stegen@kuleuven.be

Always discuss trial participation with your own doctor first.

Locations (1)

UZ LeuvenLeuven, Vlaams-Brabant, BelgiumRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06991725